Sleep News and Research

Latest Sleep News and Research

Parkinson’s disease drug Pergolide effective in treating restless legs syndrome

Pergolide, a drug commonly used to treat Parkinson’s disease symptoms, has recently been shown to be effective in treating restless legs syndrome. Researchers from seven countries collaborated on the study, published in the April 27 issue of Neurology, the scientific journal of the American Academy of Neurology.

26 Apr 2004

7,000 U.S. hospital patients die each year and more than 750,000 are injured as a result of avoidable medication mistakes

Some 7,000 U.S. hospital patients die each year and more than 750,000 are injured as a result of medication mistakes. These errors have many causes, and many potential solutions, according to a Rutgers-Camden nursing scholar who has studied the topic extensively.

23 Apr 2004

New Data Show Behavioral Education Program Helps Patients Treated with Antipsychotic Medications Reduce Weight and Improve Overall Wellness

Patients with severe and persistent mental illness treated with antipsychotic medications reported positive changes in diet, exercise, stress management, improved sleep, and increased confidence in maintaining these lifestyle changes after participating in the Solutions for Wellness Personalized Program (SFWPP), new data show.

22 Apr 2004

New developments in the treatment of pancreatic cancer

A booster dose of a substance already found in the body appears to be safe and non-toxic for the treatment of pancreatic cancer, and shows signs of arresting pancreatic cancer cell growth in patients, Penn State College of Medicine researchers report.

20 Apr 2004

Functional genomics provide improved drug discovery

Functional genomics and proteomics have been quite successful in identifying functions of potential therapeutic targets such as encoded proteins.

20 Apr 2004

Tibetan yoga helps cancer and insomnia

The first study to look at the use of Tibetan yoga by cancer patients found the combination of movement and meditation led to a significant sleep benefit, say researchers at The University of Texas M. D. Anderson Cancer Center.

16 Apr 2004

Delirium in ICU patients a predictor of mortality

Between 60 percent to 80 percent of these patients develop a brain dysfunction known as delirium, which according to a group of physicians at Vanderbilt Medical Center is an independent predictor of mortality.

16 Apr 2004

Caffeine and children, some sound advice

Many adults are dependent on the caffeine in their morning coffee to get them going. But what about kids? Children who regularly drink soda, iced tea and other caffeine-containing beverages and foods may be getting too much. Find out how caffeine can be bad for your kids (and you) -- and how much is too much.

16 Apr 2004

Sound sleep in infants lessens likelihood of drug abuse in later years

A long-term study has found a significant connection between sleep problems in children’s toddler years and the chance that they’ll use alcohol, cigarettes, and drugs early in their teen years. Young teens whose preschool sleep habits were poor were more than twice as likely to use drugs, tobacco, or alcohol.

16 Apr 2004

Survey finds most Americans are not getting enough sleep

A recent survey by the makers of TYLENOL® PM revealed America's sleep habits. It uncovered that most Americans are not getting enough sleep and how that deprivation impacts various aspects of life.

14 Apr 2004

Fixing your eyesight...while you sleep!

UNSW researchers have found the first scientific evidence that special orthokeratology (OK) contact lenses worn only while you sleep may be able to correct long-sightedness

13 Apr 2004

Drug's ability to reverse acute ischemic stroke

Ischemic stroke patients who arrive at the hospital too late to receive currently available treatment options might someday have a new treatment option. Northwestern Memorial Hospital is the only site in Chicago to participate in a phase III trial of abciximab (ReoPro - Centocor/Eli Lilly and Company), which seeks to determine the drug's ability to improve neurological function and minimize disability in patients who present with an acute ischemic stroke.

13 Apr 2004

Mercy Hospital opens new cardiovascular catheterization laboratory

The $40 million expansion of The Cardiac Centers of Mercy & Unity Hospitals reaches a significant milestone this week with the opening of the most technologically advanced cardiovascular catheterization laboratories in Minnesota.

13 Apr 2004

Breast-feeding may protect against SIDS

Breast-fed babies arouse more readily from deep sleep, Monash researchers have found, in a discovery that could help reduce deaths due to Sudden Infant Death Syndrome (SIDS).

7 Apr 2004

The Food and Drug Administration issues warning on antidepressants

The Food and Drug Administration (FDA) is issuing a warning about the possibility of worsening depression or suicidal thought in people, particularly children, who take any of 10 popular antidepressants, especially at the beginning of treatment or when the dosage is changed.

6 Apr 2004

Phase 3 study of drug teduglutide in patients with short bowel syndrome

Teduglutide is an analog of glucagon-like peptide 2 (GLP-2), a naturally occurring hormone that regulates the growth, proliferation and maintenance of cells lining the gastrointestinal tract. Teduglutide has been shown in animal studies and previous human clinical trials to increase the size and number of these cells, thereby increasing the absorptive surface area of the intestines.

6 Apr 2004

Newly formed FAS Center for Systems Neuroscience

Harvard has long been recognized for its strength in neuroscience: Researchers in the Faculty of Arts and Sciences (FAS) are leaders in studies of behavior, perception, and brain development, while Harvard Medical School (HMS) was the first in the nation to establish a department of neurobiology.

29 Mar 2004

Indiplon may help insomniacs improve their quality of sleep

Neurocrine Biosciences, Inc. has announced a second long term Phase III trial with highly positive efficacy results from its three month pivotal study, referred to as "SLEEP," the Study of Long-term Efficacy and Safety of indiplon modified release in Primary (Chronic) Insomnia patients.

24 Mar 2004

FDA approves new chewable formulation of Zyrtec® aimed at young allergy sufferers

Pfizer Inc and UCB Pharma today announced the approval of a new chewable formulation of Zyrtec® (cetirizine HCl) for the treatment of seasonal and perennial allergic rhinitis (inflammation of the nasal passages) and chronic idiopathic urticaria (itching and hives of unknown causes) in children aged two years and older. The approval by the US Food and Drug Administration makes Zyrtec the first and only prescription antihistamine available in both syrup and chewable form.

22 Mar 2004

Drug Based on Brain Chemical Could End Narcolepsy and Insomnia

Researchers at UT Southwestern Medical Center at Dallas have discovered a potentially new avenue for treating human narcolepsy, and the work may also lead to more effective ways for insomniacs to boost their wakefulness during the daytime.

22 Mar 2004